Nathan J. Dowden - President & COO at Entrada Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & COO
Stock Symbol
TRDA on Nasdaq
All Insider Reports
All Insider Reports

Nathan J. Dowden - trading volume in the past year for Entrada Therapeutics, Inc.

Holdings reported by Nathan J. Dowden for Entrada Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 181K $2.11M $11.68 Mar 3, 2025 Direct
Stock Option (Right to Buy) 90.8K Mar 1, 2025 Direct Common Stock

Transactions reported by Nathan J. Dowden for Entrada Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.